Table 2 Longitudinal lung function assessment of cohort

Pre-9/11

FEV1%

98 (90–108)

117(108–124)

<0.0001

FEV1/FVC

84 (81–87)

87 (84–89)

<0.0001

MME

FEV1%

91 (81–96)

105(97–113)

<0.0001

FEV1/FVC

84 (79–87)

85 (83–89)

<0.0001

SPE

FEV1%

93 (83–98)

113 (109–119)

<0.0001

FEV1/FVC

77 (73–79)

81 (79–84)

<0.0001

BD response

5 (2–10)

5(2–9)

0.776

BD response > 12%, N (%)

13/46 (28)

5/23 (22)

0.772

MCT slope

0.64 (0.31-0.15)

0.04(0.02-0.07)

0.010

PC20 < 10 mg/mL MCT, N (%)

17/86 (20)

6/66 (9)

0.108

TLC

103 (95–109)

106 (103–116)

0.016

RV,% Pred

125 (113–141)

111 (103–123)

0.015

DLCO

106 (99–114)

116 (108–131)

0.001

VA

93 (85–98)

100 (95–105)

<0.0001

DLCO/VA

120 (107–130)

110 (107–126)

0.358